Vienna, Austria

Friedrich Dorner

This inventor holds 91 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Cell Culture Technologies (CPC class 4352351). Top assignees: Baxter Aktiengesellschaft, Immuno Aktiengesellschaft, Baxalta Gmbh. Active years: 1977-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Friedrich Dorner. Retrieved from https://idiyas.com/inventor/friedrich-dorner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 91 

% Patents Active = 80.2


 

Average Co-Inventor Count = 3.8

ph-index = 21

Forward Citations = 1,528(Granted Patents)

Forward Citations (Not Self Cited) = 1,385(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Vienna, OE (1977)
  • Vienna, DE (2004)
  • Vienna, AT (1980 - 2020)

Company Filing History:


Years Active: 1977-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cell Cultivation
Protein-Free Media
Recombinant Cell Clones
Vaccine Production
Factor VIII
Immunogenic Formulations
Nucleic Acids
Hepatitis A Virus
Influenza Virus
Stability
Purification Methods
Antibody Derivatives
91 patents (USPTO):Explore Patents

Title: Friedrich Dorner: Pioneering Innovations in Cell Culture

Introduction

Friedrich Dorner, based in Vienna, Austria, is a distinguished inventor known for his contributions to the field of biotechnology, with an impressive portfolio of 91 patents. His innovative work predominantly focuses on developing methods and media that enhance cell cultivation processes, specifically through the elimination of animal proteins.

Latest Patents

Among his latest advancements, Dorner has pioneered animal protein-free media for the cultivation of cells. This groundbreaking invention concerns cell culture media that incorporate polyamines and plant and/or yeast-derived hydrolysates. Dorner's innovations enable cells to be cultivated, propagated, and passaged without the need for supplementary animal proteins in the culture medium. Such methodologies are particularly vital in cultivating recombinant cells or cells infected with viruses and in producing valuable biological products through cell culture processes.

Career Highlights

Throughout his career, Friedrich Dorner has contributed his expertise to notable companies, including Immuno Aktiengesellschaft and Baxter Aktiengesellschaft. His work in these influential organizations has furthered the development of critical solutions in the biopharmaceutical field.

Collaborations

Dorner has collaborated with prominent colleagues, such as Wolfgang Mundt and Johann J. Eibl. These partnerships have led to significant advancements and innovations in the life sciences sector, showcasing the power of teamwork in the research environment.

Conclusion

Friedrich Dorner's prolific output of patents reflects his unwavering commitment to driving innovation in biotechnology. His contributions, particularly in the sphere of animal protein-free cell culture media, stand as a testament to his role as a leader and visionary in the field of life sciences. As technologies continue to evolve, Dorner's work will likely serve as a foundation for future breakthroughs in cell cultivation and biological product development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…